UNIVERSITY OF ROCHESTER

UNIVERSITY OF ROCHESTER logo
🇺🇸United States
Ownership
Private
Established
1850-01-01
Employees
10K
Market Cap
-
Website
http://www.rochester.edu
Clinical Trials
Related News

Text-based Colorectal Cancer Prevention Pilot

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Behavioral: Text Messaging
First Posted Date
2021-08-13
Last Posted Date
2023-07-14
Lead Sponsor
University of Rochester
Target Recruit Count
118
Registration Number
NCT05004376
Locations
🇺🇸

Strong Hospital, Rochester, New York, United States

Telehealth Education for Asthma Connecting Hospital and Home

First Posted Date
2021-08-09
Last Posted Date
2023-11-28
Lead Sponsor
University of Rochester
Target Recruit Count
26
Registration Number
NCT04995692
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Duration of Chest Tube Suction in Traumatic Pneumothorax

Not Applicable
Withdrawn
Conditions
Traumatic Pneumothorax
Interventions
Procedure: Chest tube suction
First Posted Date
2021-08-03
Last Posted Date
2022-03-29
Lead Sponsor
University of Rochester
Registration Number
NCT04986527
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults with Myeloid Neoplasms

First Posted Date
2021-07-29
Last Posted Date
2024-12-16
Lead Sponsor
University of Rochester
Target Recruit Count
100
Registration Number
NCT04981821
Locations
🇺🇸

University of Rochester Medical Center/Wilmot Cancer Institute, Rochester, New York, United States

Emergency Department Lung Cancer URMFG Pilot

Not Applicable
Completed
Conditions
Lung Cancer
Interventions
Behavioral: Text Messaging
First Posted Date
2021-07-28
Last Posted Date
2023-08-15
Lead Sponsor
University of Rochester
Target Recruit Count
303
Registration Number
NCT04979169
Locations
🇺🇸

Strong Hospital, Rochester, New York, United States

Trial of Neratinib Plus Capecitabine in Subjects with HER2-Negative Metastatic Breast Cancer with Brain Metastases and Abnormally Active HER2 Signaling

Phase 2
Recruiting
Conditions
Breast Cancer
Interventions
Drug: Capecitabine and Neratinib.
First Posted Date
2021-07-16
Last Posted Date
2024-10-11
Lead Sponsor
University of Rochester
Target Recruit Count
22
Registration Number
NCT04965064
Locations
🇺🇸

University of Rochester, Rochester, New York, United States

Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients

First Posted Date
2021-06-28
Last Posted Date
2023-11-08
Lead Sponsor
University of Rochester
Target Recruit Count
20
Registration Number
NCT04942353
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

The Association Between Loneliness and Substance Use

First Posted Date
2021-06-24
Last Posted Date
2023-08-14
Lead Sponsor
University of Rochester
Target Recruit Count
125
Registration Number
NCT04938492
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)

Early Phase 1
Recruiting
Conditions
Thrombocytopenia
Interventions
Drug: Avatrombopag
First Posted Date
2021-06-18
Last Posted Date
2023-08-15
Lead Sponsor
University of Rochester
Target Recruit Count
24
Registration Number
NCT04931849
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

First Posted Date
2021-06-10
Last Posted Date
2024-07-24
Lead Sponsor
University of Rochester
Target Recruit Count
120
Registration Number
NCT04922281
Locations
🇺🇸

University of Rochester Medical Center, Rochester, New York, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy